Synthetic autophagy receptor

ABSTRACT

Macroautophagy/autophagy receptors target their substrates to phagophores for subsequent sequestration within autophagosomes. During phagophore membrane expansion in mammalian cells, autophagy receptors simultaneously interact with the ubiquitinated substrates and the LC3/GABARAP proteins on the expanding membrane. In this punctum, we summarize and discuss our recent research progress on synthetic autophagy receptors (AceTACs). The series of AceTACs were designed by engineering the essential interacting domains and motifs of SQSTM1/p62 (sequestosome 1), a major mammalian autophagy receptor. Particularly, we replaced the ubiquitin-associated domain of SQSTM1 with a target-specific antibody, redirecting the bifunctional interactions of wild-type SQSTM1 and directing the degradation target into the autophagy process. We successfully demonstrated the targeted degradation of aggregation-prone proteins using the AceTAC degraders. Moreover, we presented a model system with a guideline to induce targeted degradation of organelles through the autophagy machinery.

KEYWORDS:

• Antibody-fusion protein
• autophagy receptor
• targeted organelle degradation
• targeted protein degradation
• proximity-based therapeutics

Acknowledgements

We acknowledge the support from NIH/NIGMS (R01GM130145 to M.R.A.; F32GM139242 to Z.J.). The figure was partially created with BioRender.com.

Disclosure statement

We have filed a US provisional patent on this technology (No. 63/584,617).

Additional information

Funding

This work was supported by the National Institute of General Medical Sciences [F32GM139242]; National Institute of General Medical Sciences [R01GM130145].